A Phase 2 Randomized, Double Blind Placebo-Controlled, Parallel Group Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid Extended
Keyword(s):
Double blind, Individuals with Muscular Dystrophy, Placebo, Research
Core Function(s):
Performing Direct and/or Demonstration Services, Performing Research or Evaluation
Area of Emphasis
Quality Assurance, Health-Related Activities
Target Audience:
Professionals and Para-Professionals, Family Members/Caregivers, Adults with Disabilities
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
State
COVID-19 Related Data:
N/A